Production of humanized antibodies in transgenic animals
AssigneeTherapeutic Human Polyclonals, Inc.
InventorsRoland Buelow, Josef Platzer, Wim van Schooten, Jens-Ulrich Buelow
Life of this patent
Estimating the term…
Loading patent…
AssigneeTherapeutic Human Polyclonals, Inc.
InventorsRoland Buelow, Josef Platzer, Wim van Schooten, Jens-Ulrich Buelow
Estimating the term…
This invention relates to humanized antibodies and antibody preparations produced from transgenic non-human animals. The non-human animals are genetically engineered to contain one or more humanized immunoglobulin loci which are capable of undergoing gene rearrangement and gene conversion in the transgenic non-human animals to produce diversified humanized immunoglobulins. The present invention further relates to novel sequences, recombination vectors and transgenic vectors useful for making these transgenic animals. The humanized antibodies of the present invention have minimal immunogenicity to humans and are appropriate for use in the therapeutic treatment of human subjects.
A transgenic vector comprising a humanized Immunoglobulin (Ig) locus, wherein
A method of making a transgenic vector comprising a humanized Immunoglobulin (Ig) locus capable of producing a functional repertoire of humanized antibodies in a non-human animal generating antibody diversity primarily through gene conversion and/or hypermutation, comprising:
Dependencies are inferred from the claim text.